An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH

Published:2023-08 Issue:2 Volume:79 Page:552-566
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Tacke Frank^ORCID,Puengel Tobias^ORCID,Loomba Rohit,Friedman Scott L.^ORCID

Funder

National Heart, Lung, and Blood Institute

National Institute of Diabetes and Digestive and Kidney Diseases

National Center for Advancing Translational Sciences

Deutsche Forschungsgemeinschaft

National Institutes of Health

Bundesministerium für Bildung und Forschung

National Institute on Alcohol Abuse and Alcoholism

Publisher

Elsevier BV

Subject

Hepatology

Reference159 articles.

1. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review;Younossi;Hepatology,2023

2. Non-alcoholic fatty liver disease;Powell;Lancet,2021

3. Mechanisms and disease consequences of nonalcoholic fatty liver disease;Loomba;Cell,2021

4. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies;Singh;Clin Gastroenterol Hepatol,2015

5. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD;Hagstrom;J Hepatol,2017

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MAFLD-related hepatocellular carcinoma: Exploring the potent combination of immunotherapy and molecular targeted therapy;International Immunopharmacology;2024-10

2. TIR8 protects against nonalcoholic steatohepatitis by antagonizing lipotoxicity-induced PPARα downregulation and reducing the sensitivity of hepatocytes to LPS;Translational Research;2024-10

3. Fibrosis-4 score for screening of metabolic dysfunction-associated steatotic liver disease (MASLD): Data from a population-based sample in Tuscany;Nutrition, Metabolism and Cardiovascular Diseases;2024-10

4. Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein kinase activity and inhibiting Kupffer cell activation;Redox Biology;2024-10

5. The use of traditional Chinese medicine in the treatment of non-alcoholic fatty liver disease: A review;Pharmacological Research - Modern Chinese Medicine;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3